OPRX OptimizeRx Corporation
$7.29▲ +1.53%
Healthcare
Other
After hours
$7.29▲ +0.00%
Sep 11, 7:30 PM ET
Volume 115.2K
Avg Volume (10D) 158.9K
Key Metrics & Fundamentals
Market Cap
$137.31M
P/E Ratio
29.2
Div Yield
–%
52W Range
4.54 - 22.25
% vs 50 MA
2.66%
% vs 200 MA
-11.13%
RSI-14
45.8
MACD Histogram
-0.1500
Beta (1Y vs SPY)
1.96
Free Cash Flow
$8.58M
Gross Rev
$20.50M
Gross Profit
$15.69M
EBITDA
$1.10M
COGS
$4.82M
Operating Exp
$15.78M
Operating Income
-$88,000
EBIT
-$88,000
Pretax Income
-$1.10M
Net Income
-$703,000
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
GlobeNewswire · Sep 8, 2026 11:30 AM
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
GlobeNewswire · Sep 2, 2026 11:30 AM
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 11:44 PM
OptimizeRx Corporation Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 12:30 PM
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
GuruFocus.com · Aug 13, 2026 5:03 AM
OptimizeRx Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 1:04 AM
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
Zacks · Aug 12, 2026 9:40 PM
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
GlobeNewswire · Aug 12, 2026 8:05 PM
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
GlobeNewswire · Aug 12, 2026 8:01 PM
Earnings To Watch: OptimizeRx Corp (OPRX) Q2 2026 -- GF Value Sees 106% Upside
GuruFocus.com · Aug 11, 2026 1:24 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See OPRX's money flow as a full page
Social Sentiment
No Reddit posts found for OPRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.